ASTH Earnings Date: Nov 5, 2026 (Estimated) — Astrana Health, Inc.
NASDAQ · Healthcare · Medical Care Facilities
Updated
When is ASTH's next earnings date?
Astrana Health, Inc. (ASTH) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.46 on revenue of $1.02B.
How did ASTH do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Astrana Health, Inc. posted EPS of $0.40 versus the $0.34 estimate, a beat of 38.5%. Revenue was $972.5M against a $982.2M estimate. The stock's 1-day post-earnings move was +4.8%.
How much does ASTH stock move after earnings?
ASTH beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 18.2% (up or down) in the day after earnings.
About Astrana Health, Inc.
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | 0.34 | 0.40 | -38.46% | $972.5M | ✅ Beat | +4.78% | +10.72% | +12.72% |
| 2026-05-07 | Q1 2026 | 0.58 | 0.29 | -50.00% | $965.1M | ❌ Miss | +8.92% | +8.54% | +6.40% |
| 2026-03-02 | Q4 2025 | 0.26 | 0.54 | +107.69% | $950.5M | ✅ Beat | +29.46% | +22.53% | +19.72% |
| 2025-11-06 | Q3 2025 | 0.55 | 0.01 | -98.18% | $956.0M | ❌ Miss | -23.46% | -34.32% | -34.05% |
| 2025-08-07 | Q2 2025 | 0.43 | 0.19 | -55.81% | $654.8M | ❌ Miss | +30.85% | +37.65% | +37.51% |
| 2025-02-27 | Q4 2024 | 0.24 | -0.15 | -162.50% | $665.2M | ❌ Miss | -26.82% | -21.54% | -11.94% |
| 2024-11-07 | Q3 2024 | 0.32 | 0.33 | +3.12% | $478.7M | ✅ Beat | -20.51% | -29.08% | -32.28% |
| 2024-08-07 | Q2 2024 | 0.39 | 0.40 | +2.56% | $486.3M | ✅ Beat | +1.06% | +0.47% | +2.76% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q1 FY26 · $965.1M total
| Segment | Share | Revenue | YoY | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Health Care Capitation Revenue | 92.5% | $892.9M | +52.9% | $431.4M | $982.8M | $584.0M | $614.1M |
| Health Care, Patient Service | 3.9% | $37.8M | +154.1% | $18.7M | $23.7M | $14.9M | $17.9M |
| Management Service | 1.6% | $15.7M | +579.0% | $2.7M | $9.6M | $2.3M | $2.6M |
| Health Care, Other | 1.3% | $12.5M | -13.8% | $21.8M | $46.0M | $14.5M | $15.4M |
| Product and Service, Other | 0.6% | $6.2M | +30.7% | $4.1M | $7.4M | $4.7M | $4.8M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.